|
|
||||||||
CLINICAL STUDY |
Departments of Cardiovascular Sciences and 1 Endocrinology, Department of Medical Sciences, University of Cagliari, Sardinia, Italy
(Correspondence should be addressed to G Mercuro; Department of Cardiovascular Sciences, University of Cagliari, S.S. 554, bivio di Sestu, 09042 Monserrato, Cagliari, Italy; Email: mercuro{at}pacs.unica.it)
| Abstract |
|---|
|
|
|---|
Design: The aim of the present study was: (a) to further assess systolic function at rest in SH; and (b) to ascertain whether cardiac dysfunction could precede TSH increase in euthyroid patients with a high risk of developing SH.
Methods: We studied 32 patients with classical Hashimotos thyroiditis (22 with increased serum TSH (> 3 mU/ml group A), and 10 with normal serum TSH (< 3 mU/ml group B)); a third group (C), which included 13 healthy controls. All subjects underwent pulsed wave tissue Doppler imaging (PWTDI) to accurately quantify the global and regional left ventricular function.
Results: When compared with group C, PWTDI indices showed that in both groups A and B there was a significant impairment of systolic ejection (P < 0.001 and P < 0.05, respectively), a delay in diastolic relaxation (P < 0.001 and P < 0.05, respectively) and a decrease in the compliance to the ventricular filling (P < 0.05). Several significant correlations were found between PWTDI parameters and serum-free T3 and T4 and TSH concentrations.
Conclusion: PWTDI is a sensitive technique that allows detection of both diastolic and systolic abnormalities, not only in patients with SH, but also in euthyroid subjects with a high risk of developing thyroid failure. Futhermore, the significant correlations of several PWTDI indices with serum FT3 and TSH concentrations strongly support the concept of a continuum spectrum of a slight thyroid failure in autoimmune thyroiditis extending to subjects with serum TSH still within the normal range.
| Introduction |
|---|
|
|
|---|
The clinical relevance of SH is still unclear, in spite of several reports of an increased risk of low density lipoprotein (LDL)-cholesterol and negative influence on the hemostatic profile, and of increased occurrence of coronary and peripheral arterial disease and depression (14). Several mild cardiac abnormalities, such as impairment of left ventricular diastolic function at rest and of systolic function on effort have been described in SH (812). These anomalies are probably responsible for a wide spectrum of symptoms suggestive of thyroid failure observed in patients with SH (13).
In the present study, taking advantage of the peculiar sensitivity of the heart to the action of the thyroid hormone, we assessed diastolic and systolic function in patients with SH and in subjects with euthyroid autoimmune thyroiditis with normal serum TSH concentration, but at risk of developing thyroid failure. For this purpose, we used pulsed wave tissue Doppler imaging (PWTDI), a technique based on the Doppler principle, which is able to precisely assess the ventricular wall motion (14).
| Subjects and methods |
|---|
|
|
|---|
We studied 32 patients (31 females, one male) with documented classical Hashimotos thyroiditis (see below for the diagnostic criteria), whose main features are reported in Table 1
. Twenty-two of them had SH with increased serum TSH (> 3 mU/ml: 5.40 ± 2.08 mU/ml, range 3.3110.7 mU/ml; group A), and 10 had normal serum TSH (< 3 mU/ml: 2.27 ± 0.52 mU/ml, range 1.202.89 mU/ml; group B). Serum-free T3 (FT3) concentration was within the normal range in both groups. A third group included 13 healthy euthyroid controls (12 females, one male; group C). These were subjects who came to our laboratory for a thyroid function test and were found within normal values. All groups were matched for age, sex and body mass index (BMI) (Table 1
). No significant differences were observed among the groups in heart rate, blood pressure and serum FT3 concentration. Mean serum-free T4 (FT4) concentration was significantly lower and mean serum TSH significantly higher in group A when compared with group B and C. Although individual serum TSH concentration in group B was within the normal range, its mean value was significantly higher in comparison with group C.
|
The Ethical Committee of our University approved the present study, and informed written consent was obtained from all subjects. Participants were familiarized with instrumentation and medical environment of echocardiographic laboratory before testing. All subjects underwent physical examination, 12-lead electrocardiogram and M-mode, 2D and Doppler-echocardiography. Finally, subjects underwent PWTDI study, using an ultrasound system equipped with tissue Doppler imaging capabilities (SSA-380A; Toshiba Corp., Tochigi, Japan). A single experienced echocardiographer, who was unaware of the subjects thyroid conditions, carried out all examinations with subjects in the left lateral decubitus position. A simultaneous electrocardiographic tracing was also obtained.
Doppler echocardiography
A complete M-Mode, 2D, spectral- and color-Doppler recordings were performed using a 2.5-MHz transducer. Left ventricular mass (LVM) was measured according to the Devereux method (15); LVM index (LVMI) was obtained by dividing LVM by body surface area. Ejection fraction (EF) was calculated using the Simpson method (16). Pulsed Doppler transmitral flow velocities were recorded from the 4-chamber apical view, with the sample volume placed at the level of the mitral valve leaflet tips. Early (Em) and late (Am) diastolic velocities of transmitral flow were measured and the Em/Am ratio was derived. Isovolumic relaxation time (IVRT) was measured as the time interval between the end of systolic output flow and transmitral Em wave onset, by placing the sample volume between outflow tract and the mitral valve.
PWTDI
PWTDI uses the Doppler principle to assess the ventricular wall motion velocity by positioning the sample volume within the myocardium (14). In PWTDI, low-amplitude blood-flow signals are eliminated by gain adjustment to allow only high-amplitude Doppler signals from wall motion to enter the velocity calculation circuit. By means of a 4-chamber apical view, a 3 mm sample volume was placed both at the level of basal lateral and infero-septal mitral annulus, with the ultrasonic Doppler beam in a position as parallel as possible to the motion of the myocardial wall. Three distinct waves were obtained through PWTDI in each of the two mitral annular sites during the cardiac cycle: a systolic wave (S); an early diastolic wave (E) and a late diastolic wave (A). The following measurements were made from the PWTDI recordings: peak systolic velocity (Sa, cm/sec), acceleration time of S (ATSa, sec), deceleration time of S (DTSa, sec), peak early diastolic velocity (Ea, cm/sec), peak late diastolic velocity (Aa, cm/sec), acceleration time of E (ATEa, sec), and deceleration time of E (DTEa, sec). The Ea/Aa ratio was then calculated. Mean acceleration and deceleration rates of S (ARSa, cm/sec2; DRSa, cm/sec2) and of E (AREa, cm/sec2; DREa, cm/sec2) were obtained as Sa and Ea divided by their respective time intervals. These measurements were repeated on recordings of three consecutive cardiac cycles and their mean value was obtained. Then, values of basal lateral and infero-septal mitral annulus were averaged. Finally, we considered the peak early diastolic velocity of lateral mitral annulus (Eal, cm/sec) as a relaxation index. We then calculated the ratio between Em and Eal (Em/Eal), a parameter that takes into account the influence of cardiac relaxation on mitral flow (17). Reproducibility of PWTDI parameters in our laboratory had been previously documented (18).
Assessment of thyroid function
Serum TSH, FT4 and FT3, anti-thyroglobulin and anti-thyroid peroxidase antibodies (TgAb, TPOAb) were measured in all subjects. FT4 and FT3 were assayed by a direct method with chromatographic separation in Lisophase columns (Technogenetics, Milano, Italy). The normal ranges for FT4 and FT3 were 6.616 pg/ml and 2.85.6 pg/ml, respectively. Serum TSH was measured by immunochemiluminescent assay (Ortho-Clinical Diagnostic, Amersham, UK, normal range 0.33.0 mU/l). TPOAb were determined by RIA (ICN: normal range < 10 UI/ml); TgAb by passive hemoagglutination (Fujirebio Inc. Pharmaceuticals, Tokyo, Japan: normal range < 1/100). TPOAb ranged 643000 UI/ml (median 369) in group A, 1343000 UI/ml (median 379) in group B, and were negative in controls. Thyroid ultrasound was performed in all cases using a 7.5 mHz linear electronic transducer, and thyroid echogenicity was subjectively evaluated by a conventional gray scale. The diagnosis of Hashimotos thyroiditis was made on the basis of hypoechoic goiter (19) associated to high levels of TPOAb and/or TgAb (20, 21).
Statistical analysis
Data from all groups are reported as mean ± S.D. Differences between control subjects and patients were assessed by the Students 2-tailed t-test for unpaired observations. Correlations between echocardiographic parameters and PWTDI indices, and hormones (FT3, FT4 and TSH) were evaluated using Pearsons correlation coefficient. P values < 0.05 were considered to be significant.
| Results |
|---|
|
|
|---|
In comparison with controls, Em and Em/Am ratio showed a significant decrease (P < 0.05 and P < 0.001, respectively), and IVRT a significant prolongation (P < 0.001) in group A (Table 2
). Conversely, these parameters remained unmodified in group B. On the other hand, none of the echocardiographic parameters showed relevant differences between patients of group A and B. No single parameter of conventional echocardiography was correlated to serum TSH or FT3 concentration, with the exception of Em/Am ratio, which showed a significant inverse correlation (r = 0.36, P < 0.01) with serum TSH.
|
PWTDI systolic indices analysis revealed a significant impairment of the systolic ejection in both groups A and B, in comparison with group C, as shown by a decreased Sa and DRSa (P < 0.001 in group A, P < 0.05 in group B). Moreover, patients of group A showed an increase of TSa and DTSa (P < 0.05), and a decrease of ARSa and DRSa in respect to group C (P < 0.001). None of the systolic PWTDI indices showed significant differences between groups A and B. Table 3
shows PWTDI systolic indices in all the groups.
|
|
|
PWTDI diastolic recordings analysis revealed a significant impairment of both diastolic relaxation (decreased Ea, AREa, DREa and Eal, P < 0.001) and compliance to the ventricular filling (decreased Ea/Aa ratio, P < 0.001, and increased Em/Eal ratio, P < 0.05) in groups A and B as compared with group C. None of the diastolic PWTDI indices showed significant differences between Groups A and B. Table 5
displays PWTDI diastolic indices in all the three groups.
|
|
|
| Discussion |
|---|
|
|
|---|
As far as the diastolic function is concerned, our results with PWTDI are in keeping with several previous studies (for extensive reviews see (10, 11)) carried out by conventional echocardiography, documenting the presence of a significant diastolic impairment in patients with SH. With respect to conventional echocardiography, PWTDI allowed the use of Eal, a relaxation index independent from the preload, and of Em/Eal, a filling index closely correlated with the wedge pressure (17). This approach avoided the potential confounding effects of conventional echocardiography indices of left ventricular filling assessed by Doppler transmitral flow, e.g. Em/Am, which are influenced by several confounding factors such as age, heart rate, preload and afterload (22).
In contrast with the consistent findings on diastolic function, the literature provided conflicting data on systolic function in patients with SH. Biondi et al. (8) reported a significant reduction of the mean aortic acceleration, whereas peak aortic flow velocity, cardiac output, fractional shortening, and mean velocity of circumferential fiber shortening remained unaltered (8). An impairment of systolic function was observed by means of the systolic time interval, which shows the limits of an indirect method, inferred by the integration of electrocardiographic and Doppler data (9, 12). Systolic abnormalities were detected with certainty in SH only in the course of physical exercise, when the evaluation of the cardiac performance is favored by the discrepancy between the energy request and the functional cardiac reserve (8, 9, 12). In this context, SH has been found to be associated with a deranged cardio-respiratory function, both at the level of anaerobic threshold and at peak exercise (23). Evidence suggesting systolic abnormalities in SH has recently been reported by other techniques such as ultrasonic myocardial textural analysis (24), impedance cardiography (25), and radionuclide ventriculography (26).
By means of recordings performed at several sites of the mitral annulus, the PWTDI technique produces an average figure of the structure displacement velocity, which represents a reliable index of global systolic function (27). This methodological approach allowed us to demonstrate that an impairment of the systolic phase is also present at rest in patients with SH.
On account of the assumption that PWTDI is the most sensitive technique to assess the effects of subtle thyroid failure on heart contractility, we decided to use it to test the possibility that patients with autoimmune thyroiditis and normal TSH levels (i.e. those with a high risk of developing SH or overt thyroid failure) may actually be slightly hypothyroid: this condition has been recently envisaged (6, 28) but, to our knowledge, no investigation (and particularly no studies on heart contractility) has been carried out to directly address the question.
Unlike conventional echocardiography, which did not show any significant alteration in both systolic and diastolic function of patients with euthyroid autoimmune thyroiditis, PWTDI allowed us to detect a subtle but significant impairment in the whole cardiac function of these individuals. In detail, our findings were consistent in showing a significant impairment of left ventricular ejection (decreased Sa and DRSa), diastolic relaxation (decreased Ea, AREa, DREa and Eal) and ventricular filling (decreased Ea/Aa ratio and increased Em/Eal).
The degree of derangement of the above parameters found in patients with euthyroid autoimmune thyroiditis was always intermediate between patients with SH and normal euthyroid controls.
These results, along with the significant correlations of a number of PWTDI indices with thyroid hormones and TSH concentrations, strongly support the concept of a continuum spectrum of a slight thyroid failure in autoimmune thyroiditis extending to subjects with serum TSH still within the normal range. The majority of PWTDI indices were correlated to serum FT3 rather than FT4 concentrations. This proves the pivotal role of T3 in cardiac function. Moreover, some diastolic indices such as Ea/Aa, Eal and Em/Eal were significantly correlated to FT4 but not to FT3. The reason for such findings is unclear and cannot be derived from the present data. We are inclined to think that some indices may be more affected by local generation of T3 (from circulating T4) than by circulating T3. Indeed, autoimmune thyroid disease is so common in the population (up to 40% of women with lymphocytic infiltration of the thyroid and 1015% with thyroid autoantibodies) (14), that laboratory reference ranges derived from apparently healthy subjects could easily be affected by diseased individuals. In keeping with this concept, increased prevalence of TPOAb has been found in subjects with serum TSH concentrations outside the narrow range 0.21.9 mU/l, providing evidence that TSH in the upper reference range is often associated with abnormal pathology in the thyroid (7).
In conclusion, by showing an impaired systolic function in the basal condition of patients with SH, the tissue Doppler imaging has extended our knowledge of the cardiac involvement in this disease. However, the clinical relevance of this finding and the effects of L-thyroxine substitution therapy remain matters for further investigation.
| Acknowledgements |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Iqbal, H. Schirmer, P. Lunde, Y. Figenschau, K. Rasmussen, and R. Jorde Thyroid Stimulating Hormone and Left Ventricular Function J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3504 - 3510. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Turhan, C. Tulunay, M. Ozduman Cin, A. Gursoy, M. Kilickap, I. Dincer, B. Candemir, S. Gullu, and C. Erol Effects of Thyroxine Therapy on Right Ventricular Systolic and Diastolic Function in Patients with Subclinical Hypothyroidism: A Study by Pulsed Wave Tissue Doppler Imaging J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3490 - 3493. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-L. Fabrizio, D. B. Vitantonio, T. Enrica, D. C. Andrea, M. Fabio, A. Lucia, P. Caterina, C. Nadia, D. D. M. Grazia, N. Carmela, et al. Early textural and functional alterations of left ventricular myocardium in mild hypothyroidism. Eur. J. Endocrinol., July 1, 2006; 155(1): 3 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. D. Owen, C. Rajiv, D. Vinereanu, T. Mathew, A. G. Fraser, and J. H. Lazarus Subclinical Hypothyroidism, Arterial Stiffness, and Myocardial Reserve J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2126 - 2132. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |